Detalhe da pesquisa
1.
The Protective Effects of the A/ZJU01/ PR8/2013 Split H7N9 Avian Influenza Vaccine Against Highly Pathogenic H7N9 in BALB/c Mice.
Cell Physiol Biochem
; 46(2): 633-643, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29617693
2.
Potent Antiviral and Antimicrobial Polymers as Safe and Effective Disinfectants for the Prevention of Infections.
Adv Healthc Mater
; 11(9): e2101898, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694749
3.
RON receptor tyrosine kinase as a target for delivery of chemodrugs by antibody directed pathway for cancer cell cytotoxicity.
Mol Pharm
; 7(2): 386-97, 2010 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20039696
4.
Clinical significance of inflammatory cytokine and chemokine expression in hand, foot and mouth disease.
Mol Med Rep
; 15(5): 2859-2866, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28447721
5.
Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice.
Vaccine
; 34(20): 2362-70, 2016 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27013436
6.
Preclinical evaluation of the safety and pathogenicity of a live attenuated recombinant influenza A/H7N9 seed strain and corresponding MF59-adjuvanted split vaccine.
Oncotarget
; 7(49): 81012-81025, 2016 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27768591
7.
Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase.
Cancer Chemother Pharmacol
; 67(5): 1073-83, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20658288